Role of the VPS35 D620N mutation in Parkinson's disease
- PMID: 27964832
- DOI: 10.1016/j.parkreldis.2016.12.001
Role of the VPS35 D620N mutation in Parkinson's disease
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder involving the loss of dopaminergic neurons in the brain. Following the discovery of the PD-causing D620N mutation in the VPS35 (Vacuolar sorting protein 35) gene, dysfunction in the subcellular retromer complex has been strongly implicated in pathogenesis of PD. Although the function and dysfunction of the retromer has been a focus of study for some time, the role of this complex in the development of PD is not fully understood. Investigating cellular alterations that occur when the retromer is rendered dysfunctional, such as when the D620N disease-causing mutation is introduced into various model systems, shows that endosomal processing defects are major contributors to the disease phenotype. Altered trafficking of retromer cargo molecules, reduced cellular survival and altered processing of alpha-synuclein have all been observed in the presence of the D620N mutation. In addition, interactions between the retromer and the protein products of other familial Parkinsonism-related genes, has made the retromer a prime target of research in PD. This review gives an overview of the changes in retromer function, identified thus far, that may contribute to the neurodegeneration observed in PD.
Keywords: Parkinson's disease; Retromer complex; Trafficking; VPS35 D620N mutations.
Copyright © 2016. Published by Elsevier Ltd.
Similar articles
-
The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.Traffic. 2014 Feb;15(2):230-44. doi: 10.1111/tra.12136. Epub 2013 Nov 14. Traffic. 2014. PMID: 24152121
-
Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration.Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5765-5774. doi: 10.1073/pnas.1814909116. Epub 2019 Mar 6. Proc Natl Acad Sci U S A. 2019. PMID: 30842285 Free PMC article.
-
VPS35 and retromer dysfunction in Parkinson's disease.Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220384. doi: 10.1098/rstb.2022.0384. Epub 2024 Feb 19. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38368930 Free PMC article. Review.
-
Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N.Hum Mol Genet. 2015 Mar 15;24(6):1691-703. doi: 10.1093/hmg/ddu582. Epub 2014 Nov 21. Hum Mol Genet. 2015. PMID: 25416282
-
VPS35, the Retromer Complex and Parkinson's Disease.J Parkinsons Dis. 2017;7(2):219-233. doi: 10.3233/JPD-161020. J Parkinsons Dis. 2017. PMID: 28222538 Free PMC article. Review.
Cited by
-
The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review.Genes (Basel). 2023 Nov 17;14(11):2097. doi: 10.3390/genes14112097. Genes (Basel). 2023. PMID: 38003040 Free PMC article. Review.
-
The VINE complex is an endosomal VPS9-domain GEF and SNX-BAR coat.Elife. 2022 Aug 8;11:e77035. doi: 10.7554/eLife.77035. Elife. 2022. PMID: 35938928 Free PMC article.
-
Unveiling the cryo-EM structure of retromer.Biochem Soc Trans. 2020 Oct 30;48(5):2261-2272. doi: 10.1042/BST20200552. Biochem Soc Trans. 2020. PMID: 33125482 Free PMC article. Review.
-
Altered striatal dopamine levels in Parkinson's disease VPS35 D620N mutant transgenic aged mice.Mol Brain. 2020 Dec 1;13(1):164. doi: 10.1186/s13041-020-00704-3. Mol Brain. 2020. PMID: 33261640 Free PMC article.
-
Parkinson's Disease: From Pathogenesis to Pharmacogenomics.Int J Mol Sci. 2017 Mar 4;18(3):551. doi: 10.3390/ijms18030551. Int J Mol Sci. 2017. PMID: 28273839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous